Home / Recalls / Pacifico National, Inc. dba AmEx Pharmacy / D-1271-2019

D-1271-2019 Class II Terminated

Recalled by Pacifico National, Inc. dba AmEx Pharmacy — Melbourne, FL

Recall Details

Product Type
Drugs
Report Date
May 8, 2019
Initiation Date
April 19, 2019
Termination Date
February 16, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
249 syringes

Product Description

BEVACIZUMAB 1.25 mg/0.05 mL 31G MJ syringe Intravitreal Injection. This biologic product was repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901 Lot:190212AB BUD:5/13/2019, Repackaged on 2/12/2019

Reason for Recall

Defective Delivery System: difficult to express

Distribution Pattern

Nationwide in the US

Code Information

Lot: 190212AB BUD: 5/13/2019

Other recalls by Pacifico National, Inc. dba AmEx Pharmacy

  • D-1849-2019 Class II — Bevacizumab, 2.5 mg/0.1 mL, Norm-Ject Syringe Intravitreal Injection, Single use (August 30, 2019)
  • D-1850-2019 Class II — Bevacizumab, 1.25 mg/0.05 mL, 31G MJ Syringe Intravitreal Injection, Single use (August 30, 2019)
  • D-0869-2016 Class I — Avastin (Bevacizumab) 2 mg/0.08 mL syringe, Office Administration Only, AmEx Pha (January 20, 2015)
  • D-0870-2016 Class I — Avastin (Bevacizumab) 1.25 mg/0.05 mL syringe, Office Administration Only, AmEx (January 20, 2015)